The FDA-approved Zepbound KwikPen delivers a full month of treatment in one device and will be available to self-pay patients through LillyDirect starting Feb. 23.
The latest wellness craze involves injecting these molecules for athletic performance, longevity and more. Scientists say the ...
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.